Acquisition by Leonard Braden Michael of 172747 shares of Reneo Pharmaceuticals at 1.3712 subject to Rule 16b-3
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Reneo |
Filed transaction by Reneo Pharmaceuticals 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Reneo Pharmaceuticals Fundamental Analysis
We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Reneo Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Reneo Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reneo Pharmaceuticals Related Equities
| CNSP | Cns Pharmaceuticals | 10.00 | ||||
| CGEM | Cullinan Oncology | 3.37 | ||||
| HEPA | Hepion Pharmaceuticals | 2.04 | ||||
| KZR | Kezar Life | 1.86 | ||||
| SMMT | Summit Therapeutics | 1.77 | ||||
| ADPT | Adaptive Biotechnologies | 1.11 | ||||
| CELC | Celcuity LLC | 1.05 | ||||
| VIR | Vir Biotechnology | 0.54 | ||||
| IMMX | Immix Biopharma | 0.46 | ||||
| APLS | Apellis Pharmaceuticals | 0.33 | ||||
| RPRX | Royalty Pharma | 0.08 | ||||
| DNA | Ginkgo Bioworks | 0.95 | ||||
| KRON | Kronos Bio | 1.04 | ||||
| EWTX | Edgewise Therapeutics | 1.20 | ||||
| PRME | Prime Medicine, | 1.78 | ||||
| HOWL | Werewolf Therapeutics | 1.91 | ||||
| LEGN | Legend Biotech | 3.33 | ||||
| CCCC | C4 Therapeutics | 4.68 | ||||
| NKTX | Nkarta | 6.00 | ||||
| OCEA | Ocean Biomedical | 7.81 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |